Jeremy Keenan, MD
Enriched profileH. Bruce Ostler Professor of Ophthalmology; Director of International Programs, Proctor Foundation · University of California, San Francisco (UCSF)
Jeremy Keenan is H. Bruce Ostler Professor of Ophthalmology; Director of International Programs, Proctor Foundation at University of California, San Francisco (UCSF). OpenAlex indexes 418 publications with 9,819 citations (h-index 48); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Jeremy Keenan, MD, is H. Bruce Ostler Professor of Ophthalmology at University of California, San Francisco (UCSF), Department of Ophthalmology / Francis I. Proctor Foundation. The public record shows 418 publications with 9,819 citations (h-index 48), centered on Reproductive tract infections research, Ocular Infections and Treatments, Syphilis Diagnosis and Treatment. It also documents an investigator role on 13 registered clinical trials, 12 NIH-funded awards (2008–2026).
- Most recent indexed publication: 2026 · Cornea
- Top research focus: Reproductive tract infections research
- 13 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 54 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 217.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Incentives
Sponsor: University of California, San Francisco
- Strategies for Improving Linkage-to-Care After Eye Disease Screening
Sponsor: University of California, San Francisco
- Glaucoma Screening to Enhance At-Risk Californians' Health
Sponsor: University of California, San Francisco
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
55.8%Fluoroquinolone Antibacterial32.7%Moxifloxacin100%Part D<11 patientsMacrolide23.1%Erythromycin100%Part D<11 patientsSensory organs
44.2%Prostaglandin Analog23.1%Latanoprost100%Part D<11 patientsCorticosteroid21.2%Fluorometholone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
12 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring
University of California, San Francisco
FY2026$36,271R33EY033690
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Adjunctive povidone-iodine for Acanthamoeba keratitis: a randomized trial.
Antimicrobial agents and chemotherapy
Clinical Trial2026 - Allied Ophthalmic Personnel: Backbone of Aravind's Eye Care and Social Mission.
Eye (London, England)
Article2026 - Co-selection of genetic antibiotic resistance in Streptococcus pneumoniae after repeated azithromycin mass drug administrations in Niger.
Antimicrobial agents and chemotherapy
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa376 citations2018
- 04A radiation hybrid map of the zebrafish genome259 citations1999
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jeremy-keenan-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Jeremy-D-Keenan-39517466
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
ophthalmology.ucsf.edu/research-spotlight-advancing-eye-health-in-global-communities-with-jeremy-keenan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.ucsf.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Columbia University Vagelos College of Physicians and Surgeons
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.ucsf.edu ↗
- Board certified
American Board of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Principal Investigator
SWIFT trial (NEI UG1) - water/sanitation/hygiene for trachoma, Africa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.ucsf.edu ↗ - Principal Investigator
VIEW II trial (NEI UG1) - community-based screening for glaucoma, diabetic retinopathy, and macular degeneration, Nepal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.ucsf.edu ↗
Secondary affiliations
appointments beyond the home institution- Aravind Eye Hospital
South India (international research collaboration)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.ucsf.edu ↗ - Chiang Mai University
Thailand (international research collaboration)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.ucsf.edu ↗ - UCSF/UC Berkeley Center for Global Health Delivery
Diplomacy, and Economics (CGHDDE)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cghdde.berkeley.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmology.ucsf.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Gregory Marcus, MD
University of California, San Francisco (UCSF)
Eric Small, MD
University of California, San Francisco (UCSF)
Adam Boxer, MD
University of California, San Francisco (UCSF)